Item title
|
Consultant
|
| Cellular stress in lung diseases |
Prof. Dr. Veronika Müller, DSc |
| IPFdiagnostics and therapy |
Prof. Dr. Veronika Müller, DSc |
| Immunregulation in asthmatic pregnacy |
Prof. Dr. Lilla Tamási, DSc |
| Asthma and pregnancy |
Prof. Dr. Lilla Tamási, DSc |
| Asthma in pregnancy |
Prof. Dr. György Losonczy, DSc |
| The bronchial circulation |
Dr. habil. Gábor Horváth, PhD |
| Inhalation therapy of asthma and COPD |
Dr. habil. Gábor Horváth, PhD |
| Inhalation therapy of asthma and COPD |
Dr. habil. Gábor Horváth, PhD |
| Interstitial lung diseases |
Dr. Anikó Bohács, PhD |
| Lung transplantation |
Dr. Anikó Bohács, PhD |
| Inhalation treatment of pulmonary diseases |
Dr. Márta Orosz, PhD |
| Treatment of bronchial asthma-control of asthma |
Dr. Márta Orosz, PhD |
| Measurement of exercise intolerance with new techniques in chronic respiratory diseases |
Dr. habil. Tamás János Varga, PhD |
| The effect of dynamic hyperinflation on circulation in COPD |
Dr. habil. Tamás János Varga, PhD |
| The effectivity of perioperative rehabilitation in lung cancer |
Dr. habil. Tamás János Varga, PhD |
| Comparison between the effectivity of different training modality in COPD |
Dr. habil. Tamás János Varga, PhD |
| Measurement of tissue oxygenation at rest and during exercise |
Dr. habil. Tamás János Varga, PhD |
| Rehabilitation in COVID |
Dr. habil. Tamás János Varga, PhD |
| The change of pulmonary circulation, dynamics of pulmonary pressure during exercise |
Dr. habil. Tamás János Varga, PhD |
| Ethical issues of cadaver organ donation: who is dead? |
Dr. Zoltán Süttő, PhD |
| Significance of low molecular weight hyaluronan and its impact in idiopathic pulmonary arterial hypertension in patients with systemic sclerosis with and without pulmonary arterial hypertension and in patients with idiopathic pulmonary fibrosis |
Dr. Kristóf Karlócai |
| Phenotypes of COPD exacerbation |
Dr. Zsófia Lázár, PhD |
| Prediktive biomarkers of COPD exacerbation |
Dr. Zsófia Lázár, PhD |
| Assessment of airway and systemic inflammation in COPD |
Dr. Zsófia Lázár, PhD |